A protein called PIEZO1, which helps cells in blood vessels detect mechanical forces, plays a key role in driving…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has approved a generic version of Ofev (nintedanib) for easing lung scarring…
A compound called orcinol glucoside (OG) can reduce lung inflammation and scarring in mouse and cell models of idiopathic…
Treatment with Tyvaso (treprostinil) outperformed a placebo at preserving lung function and preventing clinical worsening — meaning, it led to…
Following the lifting of a regulatory hold late last year, a U.S. clinical trial testing LTI-03, an inhaled therapy for…
Regulatory authorities in both the U.S. and the European Union have granted orphan drug status to deupirfenidone (LYT-100), an oral…
Mutations in the ACVRL1Â gene may play a role in the development of idiopathic pulmonary fibrosis (IPF), and targeting the…
Treatment with the experimental oral therapy GRI-0621 modulated immune cell activity in adults with idiopathic pulmonary fibrosis (IPF) in…
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast), taken as oral tablets, as a treatment for…
Building on positive Phase 2 data, Puretech Health plans to launch a Phase 3 trial in the coming months…